Crossmark

Combining AFP, PIVKA-II, and GP73 has diagnostic utility for hepatitis B-associated hepatocellular carcinoma and is consistent with liver pathology results

Crossref DOI link: https://doi.org/10.1038/s41598-025-92067-9

Published Online: 2025-04-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rui, Hu

Yueqin, Ni

Wei, Wang

Bangtao, Li

Li, Xiao
Funding

Funding for this research was provided by:

This manuscript was supported by Taizhou People’s Hospital Scientifc Research Fund Project (QDJJ202108, QDJJ202108, QDJJ202108, QDJJ202108, QDJJ202108)
License Information

Text and Data Mining valid from 2025-04-28

Version of Record valid from 2025-04-28
More Information

Article History

Received: 21 July 2024

Accepted: 25 February 2025

First Online: 28 April 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below